Accuracy of Three Commercial Wearable Devices for Sleep Tracking in Healthy Adults
Sensors · 10.10.2024 · 24 (20) · 6532
DOI: 10.3390/s24206532 ↗Kurz gefasst
Fachartikel in der Zeitschrift Sensors, online erschienen am 10.10.2024. Verfasst von Rebecca Robbins und 10 weiteren Autor:innen. Beteiligte Einrichtung: Division of Sleep and Circadian Disorders, Brigham and Women's Hospital, Boston, MA 02115, USA. Hauptthemen laut MEDLINE: Wearable Electronic Devices, Polysomnography, Sleep. Die Arbeit wurde bisher 95-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCATS NIH HHS, Oura Ring Inc, Oura Ring Inc..
Abstract (Originalsprache)
Sleep tracking by consumers is becoming increasingly prevalent; yet, few studies have evaluated the accuracy of such devices. We sought to evaluate the accuracy of three devices (Oura Ring Gen3, Fitbit Sense 2, and Apple Watch Series 8) compared to the gold standard sleep assessment (polysomnography (PSG)). Thirty-five participants (aged 20–50 years) without a sleep disorder were enrolled in a single-night inpatient study, during which they wore the Oura Ring, Fitbit, and Apple Watch, and were monitored with PSG. For detecting sleep vs. wake, the sensitivity was ≥95% for all devices. For discriminating between sleep stages, the sensitivity ranged from 50 to 86%, as follows: Oura ring sensitivity 76.0–79.5% and precision 77.0–79.5%; Fitbit sensitivity 61.7–78.0% and precision 72.8–73.2%; and Apple sensitivity 50.5–86.1% and precision 72.7–87.8%. The Oura ring was not different from PSG in terms of wake, light sleep, deep sleep, or REM sleep estimation. The Fitbit overestimated light (18 min; p < 0.001) sleep and underestimated deep (15 min; p < 0.001) sleep. The Apple underestimated the duration of wake (7 min; p < 0.01) and deep (43 min; p < 0.001) sleep and overestimated light (45 min; p < 0.001) sleep. In adults with healthy sleep, all the devices were similar to PSG in the estimation of sleep duration, with the devices also showing moderate to substantial agreement with PSG-derived sleep stages.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Sleep and Circadian Disorders, Brigham and Women's Hospital, Boston, MA 02115, USA.
- Division of Sleep Medicine, Harvard Medical School, Boston, MA 02115, USA.
ORCID-Profile: Rebecca Robbins, Matthew D Weaver, Stuart F Quan, Katherine Gilmore, Jeanne F Duffy
Förderung
- NCATS NIH HHS
- Oura Ring Inc
- Oura Ring Inc.
- Harvard Catalyst, the Harvard Clinical and Translational Science Center
- Brigham and Women’s Hospital, Harvard University, and its affiliated academic healthcare centers
Zitieren
APA
Robbins, R., Weaver, M. D., Sullivan, J. P., Quan, S. F., Gilmore, K., Shaw, S., Benz, A., Qadri, S., Barger, L. K., Czeisler, C. A., & Duffy, J. F. (2024). Accuracy of Three Commercial Wearable Devices for Sleep Tracking in Healthy Adults. Sensors, 24(20), 6532. https://doi.org/10.3390/s24206532
Vancouver
Robbins R, Weaver MD, Sullivan JP, Quan SF, Gilmore K, Shaw S, et al. Accuracy of Three Commercial Wearable Devices for Sleep Tracking in Healthy Adults. Sensors. 2024;24(20):6532. doi:10.3390/s24206532
BibTeX
@article{Robbins2024,
author = {Robbins, Rebecca and Weaver, Matthew D and Sullivan, Jason P and Quan, Stuart F and Gilmore, Katherine and Shaw, Samantha and Benz, Abigail and Qadri, Salim and Barger, Laura K and Czeisler, Charles A and Duffy, Jeanne F},
title = {Accuracy of Three Commercial Wearable Devices for Sleep Tracking in Healthy Adults},
journal = {Sensors},
year = {2024},
volume = {24},
number = {20},
pages = {6532},
doi = {10.3390/s24206532}
}
EUVIMED